missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CDKN1A Monoclonal Antibody (OTI5G1), TrueMAB™, OriGene
Mouse Monoclonal Antibody
Brand: Origene Technologies TA808128S
This item is not returnable.
View return policy
Description
CDKN1A Monoclonal antibody specifically detects CDKN1A in Human samples. It is validated for Immunohistochemistry (Paraffin), Western BlotSpecifications
| CDKN1A | |
| Monoclonal | |
| 1 mg/mL | |
| PBS with 1% BSA, 50% glycerol and 0.02% sodium azide | |
| P08579 | |
| Mouse | |
| Affinity chromatography | |
| RUO | |
| 6629 | |
| -20° C, Avoid Freeze/Thaw Cycles | |
| IgG1 |
| Immunohistochemistry (Paraffin), Western Blot | |
| OTI5G1 | |
| Unconjugated | |
| SNRPB2 | |
| Activating Fragment 1; CAP20; cdk inhibitor CIP1; cdk inhibitor CIP1 (p21); CDKI; CDK-interacting protein 1; CDK-interaction protein 1; Cdkn1; CDKN1A; CDNK1A; CIP1; Cip1); cyclin dependent kinase inhibitor 1A; cyclin-dependent kinase inhibitor 1; cyclin-dependent kinase inhibitor 1A; Cyclin-dependent kinase inhibitor 1A (p21; cyclin-dependent kinase inhibitor 1A (P21); cyclin-dependent kinase inhibitor 1A (p21, Cip1); cyclin-dependent kinase inhibitor 1A variant 1; cyclin-dependent kinase inhibitor 1A variant 2; DNA synthesis inhibitor; MDA6; MDA-6; melanoma differentiation associated protein 6; melanoma differentiation-associated protein; Melanoma differentiation-associated protein 6; OTTHUMP00000016298; p21; p21<WAF1/CIP1>; p21Cip1; p21Cip1/Waf1; p21WAF; PIC1; putative cyclin-dependent kinase inhibitor 1A (p21/WAF1/CIP1); SDI1; SLC12A9; UV96; WAF1; Wild type p53 activated fragment 1 (WAF1); wild-type p53-activated fragment 1 | |
| Full length human recombinant protein of human SNRPB2 produced in E.coli. | |
| 30 μL | |
| Primary | |
| Human | |
| Liquid |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction